BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19953608)

  • 21. Omenn syndrome due to ARTEMIS mutations.
    Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
    Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital defects in V(D)J recombination.
    de Villartay JP
    Br Med Bull; 2015 Jun; 114(1):157-67. PubMed ID: 25987660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains.
    Niewolik D; Peter I; Butscher C; Schwarz K
    J Biol Chem; 2017 Feb; 292(8):3351-3365. PubMed ID: 28082683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.
    van der Burg M; van Veelen LR; Verkaik NS; Wiegant WW; Hartwig NG; Barendregt BH; Brugmans L; Raams A; Jaspers NG; Zdzienicka MZ; van Dongen JJ; van Gent DC
    J Clin Invest; 2006 Jan; 116(1):137-45. PubMed ID: 16357942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artemis, a novel guardian of the genome.
    Dudásová Z; Chovanec M
    Neoplasma; 2003; 50(5):311-8. PubMed ID: 14628082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
    Nahum A; Somech R; Shubinsky G; Levy J; Broides A
    Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
    Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
    J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
    Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
    Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
    Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
    J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The requirement of Artemis in double-strand break repair depends on the type of DNA damage.
    Kurosawa A; Koyama H; Takayama S; Miki K; Ayusawa D; Fujii M; Iiizumi S; Adachi N
    DNA Cell Biol; 2008 Jan; 27(1):55-61. PubMed ID: 17941805
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Bin Y; Wei S; Chen R; Zhang H; Ren J; Liu P; Xin Z; Zhang T; Yang H; Wang K; Feng Z; Sun X; Chen Z; Zhang H
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs.
    Waide EH; Dekkers JC; Ross JW; Rowland RR; Wyatt CR; Ewen CL; Evans AB; Thekkoot DM; Boddicker NJ; Serão NV; Ellinwood NM; Tuggle CK
    J Immunol; 2015 Oct; 195(7):3171-9. PubMed ID: 26320255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Artemis in DSB repair and guarding chromosomal stability following exposure to ionizing radiation at different stages of cell cycle.
    Darroudi F; Wiegant W; Meijers M; Friedl AA; van der Burg M; Fomina J; van Dongen JJ; van Gent DC; Zdzienicka MZ
    Mutat Res; 2007 Feb; 615(1-2):111-24. PubMed ID: 17169382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition.
    Yosaatmadja Y; Baddock HT; Newman JA; Bielinski M; Gavard AE; Mukhopadhyay SMM; Dannerfjord AA; Schofield CJ; McHugh PJ; Gileadi O
    Nucleic Acids Res; 2021 Sep; 49(16):9310-9326. PubMed ID: 34387696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation.
    Hönig M; Schwarz K
    Curr Opin Rheumatol; 2006 Jul; 18(4):383-8. PubMed ID: 16763459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.
    Kobayashi N; Agematsu K; Sugita K; Sako M; Nonoyama S; Yachie A; Kumaki S; Tsuchiya S; Ochs HD; Sugita K; Fukushima Y; Komiyama A
    Hum Genet; 2003 Apr; 112(4):348-52. PubMed ID: 12592555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel radiosensitive SCID patient with a pronounced G(2)/M sensitivity.
    Wiegant WW; Meyers M; Verkaik NS; van der Burg M; Darroudi F; Romeijn R; Bernatowska E; Wolska-Kusnierz B; Mikoluc B; Jaspers NG; Vreeken C; Ijspeert H; Esveldt-van Lange RE; Friedl AA; de Villartay JP; Mullenders LH; van Dongen JJ; van Gent DC; Pastink A; Zdzienicka MZ
    DNA Repair (Amst); 2010 Apr; 9(4):365-73. PubMed ID: 20079696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.
    van Zelm MC; Geertsema C; Nieuwenhuis N; de Ridder D; Conley ME; Schiff C; Tezcan I; Bernatowska E; Hartwig NG; Sanders EA; Litzman J; Kondratenko I; van Dongen JJ; van der Burg M
    Am J Hum Genet; 2008 Feb; 82(2):320-32. PubMed ID: 18252213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity.
    Woo Y; Wright SM; Maas SA; Alley TL; Caddle LB; Kamdar S; Affourtit J; Foreman O; Akeson EC; Shaffer D; Bronson RT; Morse HC; Roopenian D; Mills KD
    Oncogene; 2007 Sep; 26(41):6010-20. PubMed ID: 17384673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.